SpringerLink
Log in

Syndrome d’encéphalopathie postérieure réversible ou Posterior Reversible Encephalopathy Syndrome (PRES) secondaire au bevacizumab

Posterior Reversible Encephalopathy Syndrome (PRES) due to bevacizumab

  • Cas Clinique / Case Report
  • Published:
Annales françaises de médecine d'urgence

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. Hinchey J, Chaves C, Appignani B, et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334: 494–500

    Article  CAS  PubMed  Google Scholar 

  2. Miller K, Wang M, Gralow J, et al (2007) Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med 357:2666–76

    Article  CAS  PubMed  Google Scholar 

  3. Fugate JE, Rabinstein AA (2015) Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 14:914–25

    Article  PubMed  Google Scholar 

  4. Servillo G, Bifulco F, De Robertis E, et al (2007) Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med 33:230–6

    Article  PubMed  Google Scholar 

  5. Legriel S, Schraub O, Azoulay E, et al (2012) Determinants of recovery from severe posterior reversible encephalopathy syndrome. PLoS One 7:e44534

    Article  Google Scholar 

  6. Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. Am J Neuroradiol 29:1043–9

    Article  CAS  PubMed  Google Scholar 

  7. Glusker P, Recht L, Lane B (2006) Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med 354:980–2

    Article  CAS  PubMed  Google Scholar 

  8. Tlemsani C, Mir O, Boudou-Rouquette P, et al (2011) Posterior reversible encephalopathy syndrome induced by anti-VEGF agents. Target Oncol 6:253–8

    Article  PubMed  Google Scholar 

  9. Singer S, Grommes C, Reiner AS, et al (2015) Posterior reversible encephalopathy syndrome in patients with cancer. Oncologist 20:806–11

    Article  PubMed  PubMed Central  Google Scholar 

  10. Le EM, Loghin ME (2014) Posterior reversible encephalopathy syndrome: A neurologic phenomenon in cancer patients. Curr Oncol Rep 16:383

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service des urgences, hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (APHP), 1 avenue Claude Vellefaux, 75010, Paris, France

    O. Peyrony

  2. Service de radiologie, hôpital Saint-Louis, AP-HP, 1 avenue Claude Vellefaux, 75010, Paris, France

    C. de Margerie-Mellon

  3. Service de réanimation médicale, hôpital Saint-Louis, AP-HP, 1 avenue Claude Vellefaux, 75010, Paris, France

    E. Mariotte

Authors
  1. O. Peyrony
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. de Margerie-Mellon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Mariotte
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O. Peyrony.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peyrony, O., de Margerie-Mellon, C. & Mariotte, E. Syndrome d’encéphalopathie postérieure réversible ou Posterior Reversible Encephalopathy Syndrome (PRES) secondaire au bevacizumab. Ann. Fr. Med. Urgence (2017). https://doi.org/10.1007/s13341-017-0788-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13341-017-0788-3

Search

Navigation